Phathom Pharmaceuticals PHAT
NASDAQ PHAT
$6.12 +0.67 (+12.40%)
As of: Nov 11, 2026 · 2:59 PM EST

Phathom Pharmaceuticals (PHAT) Return on Capital Employed [ROCE] (2019 - 2026)

Updated

Phathom Pharmaceuticals (PHAT) reported Return on Capital Employed [ROCE] of -25.04% for Q2 2026, up 124.08 percentage points from -149.12% a year earlier and up 36.45 percentage points from the prior quarter.

Analysis

Phathom Pharmaceuticals (PHAT) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends

For FY2025, Phathom Pharmaceuticals posted Return on Capital Employed [ROCE] of -85.70%, up 3.71 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of -28.74 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -89.40% in FY2024 (-22.62 pp), -66.78% in FY2023 (+47.51 pp), -114.29% in FY2022 (-53.81 pp) and -60.48% in FY2021 (-3.52 pp).
  • The Q2 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2019.
  • Year over year, Return on Capital Employed [ROCE] gained in two of the last eight quarters, with an average year-over-year change of -11.68 percentage points.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q2 2026 (a gain of 124.08 percentage points); the low point was Q2 2025 (a drop of 62.23 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -61.49% (Q1 2026), -135.96% (Q4 2025) and -140.32% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Phathom Pharmaceuticals 442.66 Mn -246.70 Mn 66.36 Mn -15.80%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -15.80%
Jun 30, 2026 -25.04%
Mar 31, 2026 -61.49%
Dec 31, 2025 -135.96%
Sep 30, 2025 -140.32%
Jun 30, 2025 -149.12%
Mar 31, 2025 -109.21%
Dec 31, 2024 -93.44%
Sep 30, 2024 -100.00%
Jun 30, 2024 -86.89%
Mar 31, 2024 -60.63%
Dec 31, 2023 -58.37%
Sep 30, 2023 -63.46%
Jun 30, 2023 -82.50%
Mar 31, 2023 -117.61%
Dec 31, 2022 -109.74%
Sep 30, 2022 -85.93%
Jun 30, 2022 -93.29%
Mar 31, 2022 -88.32%
Dec 31, 2021 -71.10%
API Access

Phathom Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PHAT&period=max&api_key=YOUR_API_KEY